AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2005
Feb 11, 2005
30786_dirs_2005-02-11_b4468ec2-d341-4fb5-981c-f78805cc6770.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO)
CIK: 0000012208
Period of Report: 2005-02-09
Reporting Person: STARK JAMES R (Controller)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-09 | Incentive Stock Option (right to buy) | $57.49 | A | 1500 | Acquired | 2015-02-09 | Bio-Rad A Common Stock (1500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 5790 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.75 | 2010-09-19 | Bio-Rad A Common Stock (6500) | 6500 | Direct |
| Incentive Stock Option (right to buy) | $11.57 | 2008-02-11 | Bio-Rad A Common Stock (3000) | 3000 | Direct |
| Incentive Stock Option (right to buy) | $11.94 | 2010-02-02 | Bio-Rad A Common Stock (2500) | 2500 | Direct |
| Incentive Stock Option (right to buy) | $13.34 | 2006-02-07 | Bio-Rad A Common Stock (2210) | 2210 | Direct |
| Incentive Stock Option (right to buy) | $16.32 | 2007-02-05 | Bio-Rad A Common Stock (3000) | 3000 | Direct |
| Incentive Stock Option (right to buy) | $28.61 | 2012-02-06 | Bio-Rad A Common Stock (3000) | 3000 | Direct |
| Incentive Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (2000) | 2000 | Direct |
| Incentive Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (2300) | 2300 | Direct |
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13